No Data
No Data
Regeneron Pharma Is Maintained at Overweight by Piper Sandler
Today's Analyst Rating | NVIDIA Price Target Raised to $200 by Cantor Fitzgerald, Alphabet-C Price Target Raised to $225 by Needham
Jan 27, Wall Street analysts have updated their stock ratings today including $NVIDIA(NVDA.US)$ and $Alphabet-C(GOOG.US)$.
Piper Sandler Maintains Regeneron Pharmaceuticals(REGN.US) With Buy Rating, Cuts Target Price to $1,013
Looking Into Regeneron Pharmaceuticals's Recent Short Interest
Is Regeneron Pharmaceuticals, Inc. (REGN) the Best Falling Stock to Invest in Right Now?
Express News | America’s Top 40 High School Scientists to Compete for $1.8 Million in Awards at Prestigious Regeneron Science Talent Search